Phase I Study of Temsirolimus and Cetuximab in Adults Patients With Advanced or Metastatic Solid Tumors

Trial Profile

Phase I Study of Temsirolimus and Cetuximab in Adults Patients With Advanced or Metastatic Solid Tumors

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs Cetuximab (Primary) ; Temsirolimus (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Acronyms TORERO
  • Most Recent Events

    • 27 Sep 2017 Status changed from recruiting to completed, based on the results published in the European Journal of Cancer.
    • 01 Aug 2017 Results published in the European Journal of Cancer
    • 02 Jun 2015 Interim results (n=39) presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top